Alliqua, a US-based wound management and drug delivery company, is launching a preclinical proof-of-principal study of an experimental hydrogel transdermal patch containing lidocaine, in an effort to take advantage of the growing market for ...
Tags: Alliqua, Containing Lidocaine
Specialty pharmaceutical company Nuvo Research has announced the launch of Pliaglis (lidocaine and tetracaine) cream 7%/7% by Galderma in Europe. Galderma has worldwide marketing rights for Nuvo's Pliaglis, a topical local anesthetic ...
Tags: Nuvo Research, Pliaglis
Nuvo Research has announced the launch of Pliaglis (lidocaine and tetracaine) topical local anesthetic cream 7%/7% by Galderma Pharma in the US. Pliaglis is indicated for local analgesia for superficial aesthetic procedures including ...
Tags: Pharma, Galderma, Galderma Pharma
The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Nuvo Research's Pliaglis (lidocaine/tetracaine) 7%/7% cream. Pliaglis, a topical local anesthetic cream forms a pliable peel on the skin ...
Specialty pharmaceutical company, BioSyent Inc., said its subsidiary BioSyent Pharma has launched a sterile topical anesthetic called Cathejell Jelly 2% for the Canadian healthcare market. Cathejell Jelly 2% combines a sterile gel and ...
Tags: Sterile Anesthetic, Cathejell Jelly 2%, Canadian healthcare
The USFDA has approved Watson Laboratories' abbreviated new drug application (ANDA) for lidocaine topical patch 5%, the generic equivalent to Endo's Lidoderm. Lidocaine is an amide-type local anesthetic agent and is suggested to ...